J Korean Assoc Oral Maxillofac Surg.  2015 Dec;41(6):299-305. 10.5125/jkaoms.2015.41.6.299.

Neck dissection for oral squamous cell carcinoma: our experience and a review of the literature

• Rani P
• Bhardwaj Y
• Dass PK
• Gupta M
• Malhotra D
• Ghezta NK

• KMID: 2133176
• DOI: http://doi.org/10.5125/jkaoms.2015.41.6.299

Abstract

OBJECTIVES
This article describes our experience with neck dissection in 10 patients with oral squamous cell carcinoma.
MATERIALS AND METHODS
Between January 2007 and October 2009, 10 patients underwent primary surgery for the treatment of squamous cell carcinoma of the oral cavity. For patients with N0 disease on clinical exam, selective neck dissection (SND [I-III]) was performed. In patients with palpable cervical metastases (N+), modified radical neck dissections were performed, except in one patient in whom SND (I-III) was performed. The histopathologic reports were reviewed to assess the surgical margins, the presence of extra-capsular spread, perineural invasion, and lymphatic invasion.
RESULTS
On histopathologic examination, positive soft tissue margins were found in three patients, and regional lymph node metastases were present in five of the ten patients. Perineural invasion was noted in five patients, and extra nodal spread was found in four patients. Regional recurrence was seen in two patients and loco-regional recurrence plus distant metastasis to the tibia was observed in one patient. During the study period, three patients died. Seven patients remain free of disease to date.
CONCLUSION
Histopathological evaluation provides important and reliable information for disease staging, treatment planning, and prognosis. The philosophy of neck dissection is evolving rapidly with regard to the selectivity with which at-risk lymph node groups are removed. The sample size in the present study is small, thus, caution should be employed when interpreting these results.

Keyword

Squamous cell carcinoma; Neck dissection; Selective neck dissection

MeSH Terms

Carcinoma, Squamous Cell*
Humans
Lymph Nodes
Mouth
Neck Dissection*
Neck*
Neoplasm Metastasis
Philosophy
Prognosis
Recurrence
Sample Size
Tibia

Reference

1. Campana JP, Meyers AD. The surgical management of oral cancer. Otolaryngol Clin North Am. 2006; 39:331–348. PMID: 16580915.

2. Khatri VP, Loree TR. A logical and stepwise operative approach to radical neck dissection. Arch Surg. 2002; 137:345–351. PMID: 11888465.

3. Kowalski LP, Sanabria A. Elective neck dissection in oral carcinoma: a critical review of the evidence. Acta Otorhinolaryngol Ital. 2007; 27:113–117. PMID: 17883186.

4. Persky MS, Lagmay VM. Treatment of the clinically negative neck in oral squamous cell carcinoma. Laryngoscope. 1999; 109:1160–1164. PMID: 10401861.

5. Jalisi S. Management of the clinically negative neck in early squamous cell carcinoma of the oral cavity. Otolaryngol Clin North Am. 2005; 38:37–46. PMID: 15649497.

6. Shah JP, Andersen PE. Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. 1995; 33:3–8. PMID: 7718525.

7. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990; 160:405–409. PMID: 2221244.

8. Chiesa F. Centenary of Crile's operation. From radical to selective neck dissection. Acta Otorhinolaryngol Ital. 2006; 26:307–308. PMID: 17633148.

9. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer. 1990; 66:109–113. PMID: 2354399.

10. Davidson BJ, Kulkarny V, Delacure MD, Shah JP. Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg. 1993; 166:395–398. PMID: 8214300.

11. Spiro RH, Morgan GJ, Strong EW, Shah JP. Supraomohyoid neck dissection. Am J Surg. 1996; 172:650–653. PMID: 8988669.

12. Carlson ER, Cheung A, Smith B, Pfohl C. Neck dissections for oral/head and neck cancer: 1906-2006. J Oral Maxillofac Surg. 2006; 64:4–11. PMID: 16360851.

13. Crile GW. Excision of the cancer of the head and neck: with special reference to the plan of dissection based on one hundred and thirty two operations. JAMA. 1906; 47:1780–1786.

14. Saffold SH, Wax MK, Nguyen A, Caro JE, Andersen PE, Everts EC, et al. Sensory changes associated with selective neck dissection. Arch Otolaryngol Head Neck Surg. 2000; 126:425–428. PMID: 10722022.

15. Ferlito A, Rinaldo A, Robbins KT, Leemans CR, Shah JP, Shaha AR, et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol. 2003; 39:429–435. PMID: 12747966.

16. Andersen PE, Shah JP, Cambronero E, Spiro RH. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg. 1994; 168:499–502. PMID: 7977984.

17. Sivanandan R, Kaplan MJ, Lee KJ, Lebl D, Pinto H, Le QT, et al. Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Arch Otolaryngol Head Neck Surg. 2004; 130:1369–1373. PMID: 15611394.

18. Spiro RH, Strong EW, Shah JP. Classification of neck dissection: variations on a new theme. Am J Surg. 1994; 168:415–418. PMID: 7977963.

19. McGuirt WF Jr, Johnson JT, Myers EN, Rothfield R, Wagner R. Floor of mouth carcinoma. The management of the clinically negative neck. Arch Otolaryngol Head Neck Surg. 1995; 121:278–282. PMID: 7873143.

20. Chummun S, McLean NR, Ragbir M. Surgical education: neck dissection. Br J Plast Surg. 2004; 57:610–623. PMID: 15380694.

21. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994; 168:391–394. PMID: 7977957.

22. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol. 2011; 47:320–324. PMID: 21459661.

23. Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck. 1993; 15:308–312. PMID: 8360052.

24. Andersen PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg. 1996; 172:689–691. PMID: 8988679.

25. Spiro JD, Spiro RH, Shah JP, Sessions RB, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg. 1988; 156:286–289. PMID: 3177752.

26. Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin North Am. 1998; 31:639–655. PMID: 9687326.

27. Byers RM. Modified neck dissection. A study of 967 cases from 1970 to 1980. Am J Surg. 1985; 150:414–421. PMID: 4051103.

28. Carvalho AL, Kowalski LP, Borges JA, Aguiar S Jr, Magrin J. Ipsilateral neck cancer recurrences after elective supraomohyoid neck dissection. Arch Otolaryngol Head Neck Surg. 2000; 126:410–412. PMID: 10722018.

29. O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg. 2000; 126:360–365. PMID: 10722009.

30. Cunningham MJ, Johnson JT, Myers EN, Schramm VL Jr, Thearle PB. Cervical lymph node metastasis after local excision of early squamous cell carcinoma of the oral cavity. Am J Surg. 1986; 152:361–366. PMID: 3766864.

31. Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997; 19:14–19. PMID: 9030939.

32. Woolgar JA. Pathology of the N0 neck. Br J Oral Maxillofac Surg. 1999; 37:205–209. PMID: 10454028.

33. Khafif A, Lopez-Garza JR, Medina JE. Is dissection of level IV necessary in patients with T1-T3 N0 tongue cancer? Laryngoscope. 2001; 111:1088–1090. PMID: 11404626.

34. Kolli VR, Datta RV, Orner JB, Hicks WL Jr, Loree TR. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg. 2000; 126:413–416. PMID: 10722019.

35. Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK, et al. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002; 128:1180–1184. PMID: 12365890.

36. Traynor SJ, Cohen JI, Gray J, Andersen PE, Everts EC. Selective neck dissection and the management of the node-positive neck. Am J Surg. 1996; 172:654–657. PMID: 8988670.

37. Harish K. Neck dissections: radical to conservative. World J Surg Oncol. 2005; 3:21. PMID: 15836786.

38. Gillies EM, Luna MA. Histologic evaluation of neck dissection specimens. Otolaryngol Clin North Am. 1998; 31:759–771. PMID: 9735105.

39. Tankéré F, Camproux A, Barry B, Guedon C, Depondt J, Gehanno P. Prognostic value of lymph node involvement in oral cancers: a study of 137 cases. Laryngoscope. 2000; 110:2061–2065. PMID: 11129021.

40. Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004; 97:423–431. PMID: 15088027.

41. Shah JP, Cendon RA, Farr HW, Strong EW. Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg. 1976; 132:504–507. PMID: 1015542.

42. Kovács AF. Relevance of positive margins in case of adjuvant therapy of oral cancer. Int J Oral Maxillofac Surg. 2004; 33:447–453. PMID: 15183407.

43. Shingaki S, Nomura T, Takada M, Kobayashi T, Suzuki I, Nakajima T. The impact of extranodal spread of lymph node metastases in patients with oral cancer. Int J Oral Maxillofac Surg. 1999; 28:279–284. PMID: 10416895.

44. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994; 73:187–190. PMID: 8275423.

45. Arduino PG, Carrozzo M, Chiecchio A, Broccoletti R, Tirone F, Borra E, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg. 2008; 66:1570–1579. PMID: 18634942.

46. Geum DH, Roh YC, Yoon SY, Kim HG, Lee JH, Song JM, et al. The impact factors on 5-year survival rate in patients operated with oral cancer. J Korean Assoc Oral Maxillofac Surg. 2013; 39:207–216. PMID: 24471047.

47. Oh MS, Kang SH, Kim HJ, Zhenglin Z, Ryu JI, Nam W, et al. Overall five-year survival rate in squamous cell carcinoma of oral cavity. J Korean Assoc Oral Maxillofac Surg. 2009; 35:83–88.

48. Suárez C, Rodrigo JP, Robbins KT, Paleri V, Silver CE, Rinaldo A, et al. Superselective neck dissection: rationale, indications, and results. Eur Arch Otorhinolaryngol. 2013; 270:2815–2821. PMID: 23321797.

49. Robbins KT, Shannon K, Vieira F. Superselective neck dissection after chemoradiation: feasibility based on clinical and pathologic comparisons. Arch Otolaryngol Head Neck Surg. 2007; 133:486–489. PMID: 17520763.